Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Genetic burden of MS risk variants distinguish patients from healthy individuals but are not associated with disease activity

Research output: Contribution to journalJournal articleResearchpeer-review

  1. The role of gluten in multiple sclerosis: A systematic review

    Research output: Contribution to journalReviewResearchpeer-review

  2. Clinical utility of anti-MOG antibody testing in a Danish cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Increased cerebrospinal fluid chitinase 3-like 1 and neurofilament light chain in pediatric acquired demyelinating syndromes

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Patient awareness about family planning represents a major knowledge gap in multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Small-scale geographical variation in multiple sclerosis: A case-control study using Danish register data 1971-2013

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Evidence for oestrogen sensitivity in perinatal depression: pharmacological sex hormone manipulation study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Diagnostic value of oligoclonal bands in children: A Nationwide Population-Based Cohort Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Smoking is associated with increased disease activity during natalizumab treatment in multiple sclerosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Genome-wide gene expression in a pharmacological hormonal transition model and its relation to depressive symptoms

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Weighted genetic risk score (wGRS) was analysed for association with disease activity in more than 500 MS patients before and during interferon-beta treatment. The wGRS was higher in MS patients than in healthy controls when analysing eight HLA - and 109 non-HLA MS risk gene variants. No significant associations were observed between number of relapses prior to or during treatment with interferon-beta, both with and without HLA risk alleles included in the wGRS. In conclusion, among Danes the wGRS was higher in MS patients than controls but was not associated with the overall disease activity or response to treatment with interferon-beta.

Original languageEnglish
JournalMultiple Sclerosis and Related Disorders
Volume13
Pages (from-to)25-27
Number of pages3
ISSN2211-0348
DOIs
Publication statusPublished - Apr 2017

    Research areas

  • Adult, Alleles, Female, Genetic Predisposition to Disease, HLA Antigens, Humans, Interferon-beta, Male, Multiple Sclerosis, Polymorphism, Single Nucleotide, Risk Factors, Journal Article

ID: 52217768